18
Participants
Start Date
July 23, 2020
Primary Completion Date
January 19, 2022
Study Completion Date
February 25, 2022
Niraparib
Niraparib oral, once a day, predetermined dose.Dosing will commence on cycle 1 day 1 and will continue until the participant is taken off treatment
Dostarlimab
Dostarlimab by intravenous infusion once every cycle for as long as they remain on the study
Radiation
Radiation therapy on every other week day of cycle 2 only. Radiation will begin on Cycle 2 Day 1
Massachusetts General Hospital Cancer Center, Boston
Tesaro, Inc.
INDUSTRY
Massachusetts General Hospital
OTHER